NYSE:MCKHealthcare
Will McKesson’s (MCK) Strong Q4 Results and Massive Buybacks Recast Its Investment Narrative?
In early May 2026, McKesson reported fourth-quarter sales of US$96.30 billion and net income of US$1.68 billion, with full-year sales reaching US$403.43 billion and net income of US$4.76 billion, alongside robust earnings per share growth from continuing operations.
At the same time, McKesson completed a very large share repurchase program totaling 66.50 million shares for US$21.13 billion, a move that aligns with institutional investors’ focus on its resilient pharmaceutical distribution...